The impact of interval from surgery to chemotherapy and age in advanced-stage ovarian cancer: A GOG ancillary study.

被引：0
|
作者：
Menzin, Andrew
Java, James
Lovecchio, John L.
Chi, Dennis
Tew, William P.
Bookman, Michael A.
Lichtman, Stuart M.
机构：
[1] N Shore Univ Hosp, Manhasset, NY USA
[2] New York State Dept Hlth, Roswell Pk Mem Inst, Gynecol Oncol Grp, Buffalo, NY 14263 USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[4] Arizona Canc Ctr, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5057
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The effect of intraperitoneal chemotherapy after interval cytoreductive surgery on recurrence and survival in patients with advanced-stage ovarian carcinoma
    Kennard, J. A.
    Stephens, A. J.
    Manyam, M.
    Fitzsimmons, C. K.
    Kilowski, K. A.
    DeCoff, K. M.
    Ahmad, S.
    Pepe, J. W.
    McKenzie, N. D.
    Kendrick, J. E.
    Holloway, R. W.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 154 - 154
  • [32] Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancer
    de Lange, N. M.
    Ezendam, N. P. M.
    Kwon, J. S.
    Vandenput, I
    Mirchandani, D.
    Amant, F.
    van der Putten, L. J. M.
    Pijnenborg, J. M. A.
    CURRENT ONCOLOGY, 2019, 26 (02) : E226 - E232
  • [33] NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY FOR ADVANCED-STAGE ENDOMETRIAL CANCER
    Khaldi, H.
    Alsayed, M.
    Al Ansari, A.
    Abujubara, M.
    Elmalik, H.
    Herod, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A59 - A59
  • [34] Utilization of Primary Cytoreductive Surgery for Advanced-Stage Ovarian Cancer
    Bercow, Alexandra
    Stewart, Taylor
    Bregar, Amy J.
    Gockley, Allison
    Mazina, Varvara
    Rauh-Hain, J. Alejandro
    Melamed, Alexander
    JAMA NETWORK OPEN, 2024, 7 (10)
  • [35] NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY FOR ADVANCED-STAGE ENDOMETRIAL CANCER
    Khaldi, H.
    Alsayed, M. T.
    Al-Ansari, A.
    Abu-Jubara, M.
    Almalik, H.
    Alhyassat, S.
    Herod, J. J. O.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A79 - A80
  • [36] Impact of interval from primary cytoreductive surgery to initiation of adjuvant chemotherapy in advanced epithelial ovarian cancer
    Lee, Yoo-Young
    Lee, Jeong-Won
    Lu, Lin
    Xu, Wei
    Kollara, Alexandra
    Brown, Theodore
    Heo, Eun-Jin
    May, Taymaa
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2018, 143 (03) : 325 - 332
  • [37] Surgical Procedures and Morbidities of Diaphragmatic Surgery in Patients Undergoing Initial or Interval Debulking Surgery for Advanced-Stage Ovarian Cancer
    Gouy, Sebastien
    Chereau, Elisabeth
    Custodio, Ana Sofia
    Uzan, Catherine
    Pautier, Patricia
    Haie-Meder, Christine
    Duvillard, Pierre
    Morice, Philippe
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 210 (04) : 509 - 514
  • [38] Interval from neoadjuvant chemotherapy to interval debulking surgery in advanced ovarian cancer: Is this a prognostic indicator?
    Hariprasad, R.
    Kumar, L.
    Mookerjee, A.
    Radhakrishnan, V.
    Kumar, S.
    Mathur, S.
    Thulkar, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] AdoRN Trial: Atezolizumab in combination with neoadjuvant chemotherapy and interval cytoreductive surgery for patients with newly-diagnosed advanced-stage epithelial ovarian cancer
    Gaillard, Stephanie
    Duska, Linda
    Broadwater, Gloria
    McNally, Leah
    Lee, Paula
    Davidson, Brittany
    Previs, Rebecca
    Moss, Haley
    Berchuck, Andrew
    Nixon, Andrew
    Yi, John
    Bookman, Michael
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S61 - S61
  • [40] Primary chemotherapy followed by interval surgery in advanced ovarian cancer
    Huober, J
    Meyer, A
    Wagner, U
    Wallwiener, D
    MEDIZINISCHE WELT, 2001, 52 (04): : 101 - 105
12345